ТРАНСПЛАНТАЦИЯ ГЕПАТОЦИТОВ КАК МЕТОД ЛЕЧЕНИЯ ПЕЧЕНОЧНОЙ НЕДОСТАТОЧНОСТИ: ЭКСПЕРИМЕНТАЛЬНЫЙ И КЛИНИЧЕСКИЙ ОПЫТ
https://doi.org/10.15825/1995-1191-2010-4-53-60
Аннотация
Перед выполнением трансплантации печени для коррекции и лечения тяжелой печеночной недостаточ- ности предложено несколько способов применения гепатоцитов: в экстракорпоральных устройствах, а также путем трансплантации гепатоцитов и имплантируемых модулей, созданных на основе тканевой инженерии. Способность здоровых и устойчивых к болезням гепатоцитов осуществлять свою функцию может позволить пациентам с декомпенсированными хроническими заболеваниями печени стабилизи- ровать свое состояние и дождаться донорского органа. В предлагаемом обзоре суммированы результа- ты экспериментальной и клинической терапии болезней печени методом трансплантации гепатоцитов.
Об авторах
М. Ю. ШагидулинРоссия
Н. А. Онищенко
Россия
М. Е. Крашенинников
Россия
Список литературы
1. Дифференциальная диагностика и лечение внутрен- них болезней: Руководство для врачей. Т. 2. Болезни органов пищеварения / Под ред. А.И. Хазанова. М., 2003. С. 281–306.
2. Lui W.Y. et al. Evaluation of a simplified staging system for prognosis of hepatocellular carcinoma // J. Formos Med. Assoc. 2009. Vol. 98. No 4. P. 248–253.
3. Шагидулин М.Ю., Онищенко Н.А., Шумаков В.И. Со- временные методы лечения печеночной недостаточ-
4. ности в клинике перед трансплантацией печени // Вестник трансплантологии и искусственных орга- нов. 2006. No 3. С. 56–62.
5. Muiesan P., Girlanda R., Jassem W. et al. Single-center experience with liver transplantation from controlled non-heart-beating donors: a viable source of grafts // Ann. Surg. 2005. Vol. 242. P. 732–738.
6. United Network for Organ Sharing. http://www. unos. org.
7. Moysyk Y.G., Sharshatkin A.V., Iljanov M.I. et al. Impro- ved results of liver transplantation from extended criteria donors by shortening of the preservation, warm ische- mic and operative time // Transplant international. 2007. Vol. 20. Supl. 2. P. 275.
8. www.eurotransplant.nl/files/statistics.
9. Pietrosi G., Vizzini G.B., Gruttadauria S., Gridelli B. Clinical applications of hepatocyte transplantation // World
10. J. Gastroenterol. 2009. Vol. 15. No 17. Р. 2074–2077.
11. Strom S.C., Fisher R.A., Thompson M.T. et al. Hepato- cyte transplantation as a bridge to orthotopic liver transplantation in terminal liver failure // Transplantation. 1997. Vol. 63. P. 559–569.
12. Smets F., Najimi M., Sokal E.M. Cell transplantation in the treatment of liver diseases // Pediatr. Transplant.
13. Vol. 12. P. 6–13.
14. Palmes D., Qayumi A.K., Spiegel H.U. Liver bridging techniques in the treatment of acute liver failure // J. Invest. Surg. 2000. Vol. 3. P. 299–311.
15. Ohashi K., Park F., Kay M.A. Hepatocyte transaplantation: clinical and experimental application // J. Mol. Med. 2001. Vol. 79. P. 617–630.
16. Gupta S., Chowdhury R.J. Therapeutic potential of hepatocyte transplantation // Cell & Developmental Biology.
17. Vol. 13. P. 439–446.
18. Fox I.J., Chowdhury J.R. Hepatocyte transplantation // Am. J. of Transplantation. 2004. Vol. 4. P. 7–13.
19. Fox I.J., Roy-Chowdhury J. Hepatocyte transplantation // J. Hepatol. 2004. Vol. 40. P. 878–886.
20. Horslen S.P., Fox I.J. Hepatocyte transplantation // Transplantation. 2004. Vol. 77. P. 1481–1486.
21. Fisher R.A., Strom S.C. Human hepatocyte transplantati- on: Worldwide results // Transplantation. 2006. Vol. 82.
22. P. 441–449.
23. Fox I.J., Chowdhury J.R. Hepatocyte transplantation // Am. J. Transplant. 2004. Vol. 4. P. 7–13.
24. Malhi H., Gupta S. Hepatocyte transplantation: new horizons and challenges // J. Hepatobiliary Pancreat. Surg.
25. Vol. 8. P. 40–45.
26. Kobayashi N., Fujiwara T., Westerman K.A. et al. Prevention of acute liver failure in rats with reversibly im- mortalized human hepatocytes // Science. 2000. Vol. 287. P. 1258–1262.
27. Berry M.N., Friend D.S. High-yield preparation of isolated rat liver parenchymal cells: a biochemical and fine structural study // J. Cell Biol. 1969. Vol. 43. P. 506–520.
28. Pareja E., Martínez A., Cortés M., Bonora A., Moya Á., Sanjuán F., Gómez-Lechón M.J., Miraa J. Hepatic cell transplantation. Technical and methodological aspects // Cir. Esp. 2010. Vol. 87. P. 139–147.
29. Mitry R.R., Hughes R.D., Dhawan A. Progress in human hepatocytes: isolation, culture & cryopreservation // Se- min. Cell Dev. Biol. 2002. Vol. 13. P. 463–467.
30. Lake J. Hepatocyte transplantation // N. Engl. J. Med. 1998. Vol. 338. P. 1463–1465.
31. Baccarani U., Sanna A., Cariani A. et al. Isolation of human hepatocytes from livers rejected for liver trans- plantation on a national basis: results of a 2-year experi- ence // Liver Transpl. 2003. Vol. 9. P. 506–512.
32. Mitry R.R., Dhawan A., Hughes R.D. et al. One liver, three recipients: segment IV from split-liver procedu- res as a source of hepatocytes for cell transplantation // Transplantation. 2004. Vol. 77. P. 1614–1616.
33. Allen K.J., Soriano H.E. Liver cell transplantation: The road to clinical application // J. Lab. Clin. Med. 2001. Vol. 138. P. 298–312.
34. Sandhu J.S., Petkov P.M., Dabeva M.D., Shafritz D.A. Stem cell properties and repopulation of the rat liver by fetal liver epithelial progenitor cells // Am. J. Pathol. 2001. Vol. 159. P. 1323–1334.
35. Raper S.E., Grossman M., Rader D.J. et al. Safety and Feasibility of Liver-Directed ex vivo Gene Therapy for Homozygous Familial Hypercholesterolemia // Ann. Surg. 1997. Vol. 223. P. 116–126.
36. Eiseman B. Treatment of liver failure // Read AE, ed. Colston Papers No 19 The Liver. London: Butterworths, 1967. 279 р.
37. Guha C., Parashar B., Deb N.J. et al. Normal hepatocy- tes correct serum bilirubin after repopulation of Gunn rat liver subjected to irradiation / partial resection // Hepato- logy. 2002. Vol. 36. P. 354–362.
38. Kobayashi N., Ito M., Nakamura J. et al. Hepatocyte transplantation in rats with decompensated liver cirrho- sis // Hepatology. 2000. Vol. 31. P. 851–857.
39. Nussler A., Konig S., Ott M. et al. Present status and perspectives of cell-based therapies for liver diseases // J. Hepatol. 2006. Vol. 45. P. 144–159.
40. Hasirci V., Berthiaume F., Bondre S.P. et al. Expressi- on of liver-specific functions by rat hepatocytes seeded in treated poly(lactic-co-glycolic) acid biodegradable foams // Tissue Eng. 2001. Vol. 7. P. 385–394.
41. Ranucci C.S., Kumar A., Batra S.P., Moghe P.V. Control of hepatocyte function on collagen foams: Sizing matrix pores toward selective induction of 2-D and 3-D cellular morphogenesis // Biomaterials. 2000. Vol. 21. P. 783– 793.
42. Shagidulin M.U., Onishchenko N.A., Krasheninni- kov M.E. et al. Working-out of intracorporated bioartifi- cial liver support unit // Journal of artificial organs. 2008. Vol. 31. No 7. P. 656.
43. Shagidulin M.U., Krasheninnikov M.E., Ilinsky I.M. et al. Matrix ElastoPOB®3-D as a basis for immobilisation of tissue-specific and nonspecific cells and prolonged cel- lular-mediated inductive Influences on damaged organ // The International Journal of Artificial Organs. 2009. Vol. 32. No 7. P. 449–450.
44. Shagidulin M.U., Krasheninnikov M.E., Ilinsky I.M. et al. The long-term surviving in vivo autologus hepa- tocytes on 3D matrixes as a path of building of a hyb- rid liver // Organ Donation Congress 10th ISODP & 16th ETCO. 2009. Oct. P. 91.
45. Uyama S., Kaufmann P.M., Kneser U. et al. Hepatocyte transplantation using biodegradable matrices in ascor- bic acid-deficient rats: comparison with heterotopically transplanted liver grafts // Transplantation. 2001. Vol. 71. No 10. P. 1–7.
46. Malhi H., Irani A.N., Gagandeep S., Gupta S. Isolation of human progenitor liver epithelial cells with extensive replication capacity and differentiation into mature hepa- tocytes // Journal of Cell Science. 2002. P. 2679–2688.
47. Mitry R.R., Dhawan A., Hughes R.D. et al. Hepatocy- te transplantation for liver-based metabolic disorders // J. Inherit. Metabol. Dis. 2006. Vol. 29 (2–3). P. 431–435.
48. Sokal E.M. Liver transplantation for inborn errors of liver metabolism // J. Inherit. Metab. Dis. 2006. Vol. 29. P. 426–430.
49. Grossman M., Rader D.J., Muller D.W. et al. A pilot stu- dy of ex vivo gene therapy for homozygous familial hy- percholesterolaemia // Nat. Med. 1995. Vol. 1. P. 1148– 1154.
50. Mazaris E.M., Roussos C.T., Papalois V.E. Hepatocyte transplantation: a review of worldwide clinical develop- ments and experiences // Exp. Clin. Transplant. 2005. Vol. 3. P. 306–315.
51. Strom S.C., Chowdhury J.R., Fox I.J. Hepatocyte trans- plantation for the treatment of human disease // Semin. Liver Dis. 1999. Vol. 19. P. 39–48.
52. Fox I.J., Chowdhury J.R., Kaufman S.S. et al. Treat- ment of the Crigler–Najjar syndrome type I with hepa- tocyte transplantation // N. Engl. J. Med. 1998. Vol. 338. P. 1422–1426.
53. Strom S.C., Fisher R.A., Rubinstein W.S. et al. Transplan- tation of human hepatocytes // Transplant. Proc. 1997. Vol. 29. P. 2103–2106.
54. Bilir B.M., Guinette D., Karrer F. et al. Hepatocyte Transplantation in Acute Liver Failure // Liver Trans- plantation. 2000. Vol. 6. P. 32–40.
55. Mito M., Kusano M., Kawaura Y. Hepatocyte transplan- tation in man // Transplant. Proc. 1992. Vol. 24. P. 3052– 3053.
Рецензия
Для цитирования:
Шагидулин М.Ю., Онищенко Н.А., Крашенинников М.Е. ТРАНСПЛАНТАЦИЯ ГЕПАТОЦИТОВ КАК МЕТОД ЛЕЧЕНИЯ ПЕЧЕНОЧНОЙ НЕДОСТАТОЧНОСТИ: ЭКСПЕРИМЕНТАЛЬНЫЙ И КЛИНИЧЕСКИЙ ОПЫТ. Вестник трансплантологии и искусственных органов. 2010;12(4):53-60. https://doi.org/10.15825/1995-1191-2010-4-53-60
For citation:
Shagidulin M.Y., Onishchenko N.A., Krasheninnikov M.E. TRANSPLANTATION OF HEPATOCYTES AS THE METHOD OF TREATMENT OF LIVER FAILURE: EXPERIMENTAL AND CLINICAL EXPERIENCE. Russian Journal of Transplantology and Artificial Organs. 2010;12(4):53-60. (In Russ.) https://doi.org/10.15825/1995-1191-2010-4-53-60